Dementia Matters by Wisconsin Alzheimer‘s Disease Research Center

193 - Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity

Dementia Matters is a podcast about Alzheimer‘s disease and other causes of dementia. Host Dr. Nathaniel Chin interviews leading scientists and caregiving experts to bring listeners the latest in Alzheimer’s disease news, research and caregiver resources. Brought to you by the Wisconsin Alzheimer’s Disease Research Center, find show notes and more resources at adrc.wisc.edu/dementia-matters.

More episodes

193 - Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity

Fri, 26 Apr 2024
192 - Living with Lewy Body: A Neurologist’s Journey Through Research and Dementia Care

Thu, 11 Apr 2024
191 - The Fundamentals of Neuropsychology: Breaking Down Cognition, Memory and More

Tue, 26 Mar 2024
190 - Long COVID and Its Effect on Cognition

Tue, 12 Mar 2024
189 - Listen Up! The Connections Between Hearing Loss, Hearing Interventions and Cognitive Decline

Wed, 28 Feb 2024
188 - From Caregiver to Research Participant: How One Woman’s Experience as a Dementia Caregiver Drew Her to Alzheimer’s Research

Tue, 13 Feb 2024
187 - Looking at Lecanemab’s Eligibility Guidelines and Prescription Process

Tue, 23 Jan 2024
186 - Do Non-Medicinal Interventions Reduce Dementia Risk? Studies are Inconclusive, Here’s Why

Tue, 09 Jan 2024
185 - The Road to Hope: Philanthropy’s Impact on Alzheimer’s Research

Tue, 26 Dec 2023
184 - Could Green Tea Hold the Key to New Alzheimer’s Treatments?

Wed, 13 Dec 2023
183 - The Impact of Social Isolation on Dementia Risk in Older Adults

Tue, 28 Nov 2023
182 - Memories and Milestones: Celebrating Six Years of ‘Dementia Matters’

Tue, 14 Nov 2023
181 - Crosswords or Computers: Which is Better for Cognitive Engagement?

Wed, 25 Oct 2023
180 - RAISE(ing) Support for Caregivers: State and National Resources for Family Care Partners

Tue, 10 Oct 2023
179 - Mental Health and Memory: The Connections between Chronic Mental Illness and Dementia

Tue, 19 Sep 2023
178 - Highlights from the 2023 Alzheimer’s Association International Conference

Tue, 05 Sep 2023
177 - A Fair Fight Against Alzheimer’s: The Need for Equity in Dementia Research and Care

Wed, 23 Aug 2023
176 - Agitation and Alzheimer’s: Strategies for Managing Behavioral and Psychological Symptoms of Dementia

Tue, 08 Aug 2023
175 - Promises to Practice: Creating Sustainable Community Partnerships to Support Alzheimer’s Research

Wed, 26 Jul 2023
174 - Study Shows APOE Gene Affects Hispanic Populations’ Risk of Cognitive Decline Differently to Non-Hispanic Populations

Wed, 12 Jul 2023
173 - Putting Lecanemab into Practice: A Clinician’s Perspective on the New Alzheimer’s Treatment

Fri, 07 Jul 2023
172 - Deciding to Donate: Barriers and Benefits of Brain Donations for Diverse Populations

Wed, 28 Jun 2023
171 - Lecanemab, Clinical Trials, and the Importance of Clinical Meaningfulness

Wed, 14 Jun 2023
170 - Understanding the Social Determinants of Health and Disparities in Alzheimer’s Research

Thu, 01 Jun 2023
169 - Take Care of Your MIND: Reviewing the MIND Diet for Healthy Brain Aging

Tue, 16 May 2023
168 - The National Strategy for Diversifying Alzheimer’s Research

Tue, 02 May 2023
167 - The Future of Neuroscience: Early-Career Researchers Named ’One to Watch’ by the Alzheimer’s Association

Tue, 25 Apr 2023
166 - Studies Look at Generational Differences and Associations between Cognition, Sensory Changes and Blood Biomarkers

Thu, 20 Apr 2023
165 - Disclosing Alzheimer’s Disease Biomarker Results in Diverse Populations

Tue, 04 Apr 2023
164 - Difficult but Beneficial Conversations about End-of-Life Care

Tue, 21 Mar 2023
163 - Caregiving While Black: Dementia Care for Different Racial and Ethnic Groups

Wed, 08 Mar 2023
162 - Our Evolving Understanding of Mild Cognitive Impairment

Tue, 21 Feb 2023
161 - A Closer Look at the Lecanemab Clinical Trials

Thu, 16 Feb 2023
160 - Therapeutic Fibbing: Mastering the Art of Communicating with a Loved One with Dementia

Tue, 07 Feb 2023
159 - The Future of the Alzheimer’s Association: Interview with Dr. Joanne Pike and Harry Johns

Tue, 24 Jan 2023
158 - Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval

Tue, 17 Jan 2023
157 - Healthy Habits for the New Year and Modifiable Risk Factors for Alzheimer’s Disease

Tue, 10 Jan 2023
156 - Bioenergetics: How Mitochondria Affects Alzheimer’s Disease and Aging

Thu, 29 Dec 2022
155 - Looking Toward the Future: How Preclinical Alzheimer’s Disease Biomarker Disclosures Impact Society

Tue, 13 Dec 2022
154 - Mixed Dementia, Explained

Tue, 29 Nov 2022
153 - The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants

Tue, 15 Nov 2022
152 - Promoting Open Science and Community Engagement with the National Institute on Aging

Tue, 01 Nov 2022
151 - Moving into the Digital Era of Alzheimer’s Disease Research

Tue, 25 Oct 2022
150 - National Efforts to Standardize Brain Scan Data for More Accurate Alzheimer’s Risk Predictions

Tue, 18 Oct 2022
149 - Protecting Participant Privacy and Making Predictions Using Alzheimer’s Data

Tue, 11 Oct 2022
148 - The Future of Sharing and Accessing Alzheimer’s Disease Data

Tue, 04 Oct 2022
147 - Introducing the National Alzheimer’s Coordinating Center

Tue, 27 Sep 2022
146 - Study Shows APOE e4 Not Associated with Alzheimer’s Disease in American Indian Populations

Tue, 13 Sep 2022
145 - Improving Registries and Representation in Alzheimer’s Disease Research

Fri, 26 Aug 2022
144 - Highlights from the 2022 Alzheimer’s Association International Conference

Wed, 10 Aug 2022

Show more episodes

More health podcasts

More health international podcasts

Find your radio station